Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Organic Letters|August 27, 2005
Shortcut to fmoc-protected phosphinic pseudodipeptidic blocksMagdalini Matziari, Athanasios YiotakisOrganic Letters|May 19, 2006
Active methylene phosphinic peptides: a new diversification approachMagdalini Matziari, Magdalini Nasopoulou, Athanasios YiotakisMedicinal Research Reviews|May 20, 2006
Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitorsMagdalini Matziari, Vincent Dive, Athanasios YiotakisThe Journal of Organic Chemistry|October 2, 2008
Synthesis of the phosphinic analogue of thyrotropin releasing hormoneMagdalini Matziari, Karl Bauer, Vincent Dive, et al.The Journal of Organic Chemistry|December 2, 2006
Chemoselective protection of solid-phase compatible Fmoc-phosphinic building blocksMagdalini Nasopoulou, Magdalini Matziari, Vincent Dive, et al.The Journal of Physical Chemistry. B|December 18, 2009
Conformational and solvation studies via computer simulation of the novel large scale diastereoselectively synthesized phosphinic MMP inhibitor RXP03 diluted in selected solventsMagdalini Matziari, Dimitris Dellis, Vincent Dive, et al.The Journal of Organic Chemistry|August 25, 2007
A versatile annulation protocol toward novel constrained phosphinic peptidomimeticsMagdalini Nasopoulou, Dimitris Georgiadis, Magdalini Matziari, et al.Journal of Medicinal Chemistry|January 9, 2004
Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11Magdalini Matziari, Fabrice Beau, Philippe Cuniasse, et al.Journal of Medicinal Chemistry|March 8, 2008
Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2Andreas Mores, Magdalini Matziari, Fabrice Beau, et al.International Journal of Cancer|October 23, 2004
Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinasesVincent Dive, Kumari L Andarawewa, Anne Boulay, et al.Pageof 5